The results display that the enhanced expression of TROAP is associated with attenuated immune cell infiltration, decreased stromal and immune activation, and diminished activity of the cancer immune cycle, which may be accounting for the poor prognosis of STS with TROAP overexpression. The gene discussed is TROAP; the disease is telomere syndrome.